SBI Securities Co., Ltd. SPRY ARS Pharmaceuticals Inc

Ownership history in SBI Securities Co., Ltd.  ·  7 quarters on record

AI Ownership Summary

SBI Securities Co., Ltd. reported ARS Pharmaceuticals Inc (SPRY) in 7 quarterly 13F filings from 2024 Q4 through 2026 Q2. Peak portfolio weight reached 0.01% in 2024 Q4. The latest visible filing shows SPRY at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this SPRY ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SBI Securities Co., Ltd.'s position in ARS Pharmaceuticals Inc, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

SPRY was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.01% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How SBI Securities Co., Ltd. held SPRY — position size vs. price
% of Fund (quarterly)    SPRY price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 ADDED 2,115 +1,465 +225.4% 0.00% $17K 2026-07-23 $6.00
2026 Q1 REDUCED 13.2% +6.6% 650 -99 -13.2% 0.00% $5K 2026-04-28 $7.94
2025 Q4 ADDED 749 +51 +7.3% 0.00% $9K 2026-02-03 $10.15
2025 Q3 ADDED 698 +48 +7.4% 0.00% $7K 2025-11-05 $9.05
2025 Q2 REDUCED 650 -7 -1.1% 0.00% $11K 2025-08-08 $17.50
2025 Q1 REDUCED 96.0% +38.7% 657 -15,896 -96.0% 0.00% $8K 2025-05-02 $14.46
2024 Q4 INITIATED 16,553 0.01% $175K 2025-02-06 $12.80

FAQ About SBI Securities Co., Ltd. and SPRY

These are the practical questions this page is built to answer before you even open the full history table.

How long has SBI Securities Co., Ltd. reported owning SPRY?

SBI Securities Co., Ltd. reported SPRY across 7 quarterly 13F filings, from 2024 Q4 through 2026 Q2.

What was the largest reported SPRY position in SBI Securities Co., Ltd.'s portfolio?

The largest reported portfolio weight for SPRY was 0.01% in 2024 Q4.

What is the latest reported SPRY position on this page?

The most recent filing on this page is 2026 Q2, when SBI Securities Co., Ltd. reported 2,115 shares, equal to 0.00% of portfolio, with an estimated market value of $17K.

What does the chart on this SPRY ownership page compare?

The chart compares SBI Securities Co., Ltd.'s quarterly SPRY portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did SBI Securities Co., Ltd. time their SPRY position?

Based on 13F filing dates vs. subsequent SPRY price moves, SBI Securities Co., Ltd. correctly timed 4 out of 6 reported position changes (67%). The annualised alpha on SPRY relative to SPY over the holding period was -48.7%.

← Back to SBI Securities Co., Ltd. Holdings